Skip to search formSkip to main contentSkip to account menu

Livostin

Known as: Taxandria Brand of Levocabastine Hydrochloride, livocab, Janssen Brand of Levocabastine Hydrochloride 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

Levocabastine hydrochloridePiperidineslevocabastine
Lvophtalevocabastine 0.5 MG/ML Ophthalmic Suspension [Livostin]levocabastine Ophthalmic Suspension [Livostin]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Ocular allergy symptoms induced by Japanese cedar pollen in an environmental exposure unit: clinical efficacy of levocabastine hydrochloride (Livostin) eye drops 0.025% and olopatadine hydrochloride…
2005
2005
Allergic conjunctivitis and uveitis models: Reappraisal with some marketed drugs
The purpose of this study was to assess the activity of some marketed products in ocular non-immune and immune type I… 
2003
2003
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
BACKGROUND Recent decades have been marked by an increasing number of patients suffering from ocular allergic-like symptoms… 
2001
2001
[The curative effect of livostin spray on treating allergic rhinitis of children].
OBJECTIVE To observe the effect of Livostin spray on children's allergic rhinitis and to search the mechanism of treating… 
2000
2000
Silicone IOL Biocompatibility — Not All Silicone
  • 2000
  • Corpus ID: 5698420
In their recent paper, Chang and coauthors 1 suggest that silicone lenses should be avoided in phacotrabeculectomy on the basis… 
1997
1997
[An open and controlled study of effectiveness and tolerance of Livostin eyedrops].
The authors present the result of an open controlled trial of the effectiveness of a new antiallergic ophthalmological… 
1992
1992
LEVOCABASTINE-NEUSSPRAY (LIVOCAB)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)